2026年11月2日星期一
M
Hoàn Vũ Thông Giám
Tin nhanh toàn cầu
Japan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaAI dubbing to help Japanese companies expand global outreach— 日经 Nikkei AsiaIndonesia GDP, US midterm elections, Hong Kong financial summit— 日经 Nikkei AsiaPakistan refineries report 1,860% jump in profit amid war windfall— 日经 Nikkei AsiaAfter US midterms, democracy will face test of ability to self-correct— 日经 Nikkei AsiaThai reformists became too technocratic, party ex-leader Pita says— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaAI dubbing to help Japanese companies expand global outreach— 日经 Nikkei AsiaIndonesia GDP, US midterm elections, Hong Kong financial summit— 日经 Nikkei AsiaPakistan refineries report 1,860% jump in profit amid war windfall— 日经 Nikkei AsiaAfter US midterms, democracy will face test of ability to self-correct— 日经 Nikkei AsiaThai reformists became too technocratic, party ex-leader Pita says— 日经 Nikkei Asia

Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders

Nguồn 英国政府公告2 ngày trước
Tóm tắt nội dung

MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.

Trang này chỉ cung cấp tiêu đề và chỉ mục tóm tắt, toàn bộ nội dung và bản quyền đều thuộc về bên phát hành gốc, vui lòng nhấp vào liên kết gốc để đọc.

Đi tới bài gốc
Kênh trực thuộc
Quốc tế
Khu vực trực thuộc
Vương quốc Anh
Ngôn ngữ gốc
English
Số mục
world-d38ac368

Comments 0 comments

No comments yet. Be the first.

Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders · Hoàn Vũ Thông Giám